Which pill stops the itch? new study pits bilastine against levocetirizine for hives
NCT ID NCT07365683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different antihistamine treatments in 60 adults with chronic hives (itchy welts that keep coming back). One group took a higher dose of bilastine, the other took a mix of bilastine and levocetirizine. The goal was to see which approach better reduces itching and welts over 6 weeks. The results help doctors choose the best treatment for symptom control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
combined military hospital ,Okara
Okāra, Punjab Province, 56300, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug aims to quiet chronic hives
- New pill for chronic hives enters first human tests
- New pill aims to quiet chronic hives without the itch
- New pill aims to stop chronic hives fast when antihistamines fail
- New pill for chronic hives tested in everyday clinics
- New hope for chronic hive sufferers: phase 3 drug trial shows promise